$AIP

Bayview Legacy, LLC sold $2.4M of AIP (indirect holdings)

Bayview Legacy, LLC sold 70,000 indirectly-held shares of Arteris, Inc. (AIP) at an average of $34.91 ($34.74–$35.16, $2.44M total) across 2 trades on 2026-06-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Jun 10, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosure provides concrete trade size, execution date, and pricing range for a 10% owner sale, which can influence short-term sentiment/positioning but does not establish new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity or changes in selling cadence, but the 10b5-1 framing limits interpretive value.

03

What to watch

Traders may over-weight insider-sale optics; the key is whether there are concurrent fundamental updates (none provided here).

Relevance 5/10Novelty 8/10Timing: Filed 2026-06-10; sale executed 2026-06-08.

Background

This is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Bayview Legacy, LLC (10% owner) sold 70,000 AIP shares in open-market trades for ~$2.44M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any move would be more sentiment/flow-driven than fundamentals.

Evidence & confidence

The filing is a primary-source insider transaction with disclosed size and pricing, but it explicitly references a pre-arranged 10b5-1 plan, reducing inference about new information.

Market effects

No sector-level read-through; this is company-specific ownership/flow information.

None indicated.

None indicated.

Counterpoint

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect routine liquidity rather than bearish expectations.

Key entities

  • Arteris, Inc.

    Company whose shares were sold by a 10% owner via open-market transactions.

  • Bayview Legacy, LLC

    10% owner who sold 70,000 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to